Viral Hepatitis

Tens of thousands of new cases of viral hepatitis occur every year in the United States. Viral hepatitis is a serious public health threat that kills thousands of Americans annually and is a leading cause of liver cancer. Hepatitis A and hepatitis B are vaccine-preventable and hepatitis C can be cured. The Viral Hepatitis Surveillance Report — United States, 2022 presents information from the ongoing, systematic collection, analysis, and interpretation of viral hepatitis-related data.

In 2019, NASTAD Drug User Health received CDC funding to oversee a demonstration project that would fund syringe services programs (SSPs) to provide patient navigation services for participants. Between 2020 and 2022, eight SSPs around the United States developed and implemented patient navigation services to facilitate engagement with medical and social services for people who use drugs (PWUD).

This is an interactive map from HepVu that demonstrates opioid prescription in the United States in 2021.

This is an interactive map from HepVu that demonstrates overdose mortality in the United States in 2021.

Community health workers can send out this postcard to educate their communities about hepatitis B. The intended audience includes the Micronesian population.

This infographic discusses the facts about hepatitis B and is intended for the Micronesian population.

This fact sheet addresses common questions about hepatitis B and is intended for the Micronesian population.

This fact sheet is intended for community health workers and the Micronesian population. It entails information they can share with their communities on hepatitis B.

This discussion guide addresses what questions one should ask their doctor after a hepatitis B diagnosis.

This infographic discusses how hepatitis is spread from person to person. It is intended for the Micronesian population.